a phase 2 trial of DDMVAC and bevacizumab in urothelial cancer
收藏NIAID Data Ecosystem2026-04-25 收录
官方服务：
资源简介：
A prognostic gene expression signature in chemotherapy-naïve bladder cancer is predictive of clinical outcomes from neoadjuvant chemotherapy 61 FFPE bladder tumors were used to validate chemo-resistant subtype in bladder cancer
创建时间：
2019-07-03
